Ardour Capital Downgrades Metabolix (MBLX) to Reduce
MBLX Hot Sheet
Rating Summary:0 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Ardour Capital downgrades Metabolix (Nasdaq: MBLX) to Reduce. Price target $8.
To see more analyst ratings on MBLX Click Here.
Metabolix, Inc., a bioscience company, develops and commercializes alternatives to petrochemical-based plastics, chemicals, and energy.
To see more analyst ratings on MBLX Click Here.
Metabolix, Inc., a bioscience company, develops and commercializes alternatives to petrochemical-based plastics, chemicals, and energy.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Brean Murray Carret & Co. Downgrades NetApp (NTAP) to Hold; Visibility Challenged
- Mizuho Securities Downgrades Dell (DELL) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
